OneOme
Minneapolis
About OneOme
A partnership of the Mayo Clinic & Invenshure, OneOme analyzes patient DNA via the most complex multi-gene algorithm in the marketplace. Working with physicians and health care providers, we minimize errors and failures and advance efficacy and safety. Applied across the majority of pharmaceutical medicine, the result is an actionable, at-a-glance prescription recommendation report that is absolutely personalized to each patient. The next level of pharmaceutical efficiency and safety is here.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.4M
- Last round: Debt Financing (Jun 2017)
- Website: oneome.com
- Phone: (612) 200-1039
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/oneome-48376 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.